Certara, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Certara, Inc. on October 16, 2024. The report discloses a corporate governance change involving the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial performance data.
Material Changes
The Board of Directors increased its size from nine (9) to ten (10) members. Dr. John V. W. Reynders was appointed as a Class II director and a member of the Audit Committee, effective immediately.
Outlook, Risks, and Management Commentary
- Director Tenure: Dr. Reynders will serve until the 2025 annual meeting of stockholders or until his successor is elected, or until earlier death, disqualification, or removal.
- Compensation: Dr. Reynders will receive compensation in accordance with the Company's non-employee director compensation policy detailed in the Definitive Proxy Statement filed on April 10, 2024.
- Indemnification: The Company intends to enter into an indemnification agreement with Dr. Reynders similar to those held by other board members.
- Conflicts of Interest: There are no family relationships between Dr. Reynders and existing directors or officers, and no transactions requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify Dr. John V. W. Reynders' professional background and qualifications for the Audit Committee.
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 10, 2024, for specific details on non-employee director compensation.
- Confirm the updated Board composition and committee assignments in subsequent filings.